ArticleCNS neuroscience & therapeutics2026

SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment.

Yanan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.